Arthur Taveras serves as Executive at X4 Pharmaceuticals, Inc, where they oversee executive responsibilities. Since joining the company, Arthur Taveras has executed 9 insider transactions totaling $77.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 11, 2024 involved selling 14,235 shares valued at $12.5K.
Arthur Taveras currently holds 234,301 shares of X4 Pharmaceuticals, Inc (XFOR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Arthur Taveras has been a net seller of XFOR stock. They have purchased $0 and sold $77.7K worth of shares.
Arthur Taveras's most recent insider trade was on Mar 11, 2024, when they sold 14,235 shares at $0.88 per share.
Get notified when new Form 4 filings are submitted
| $1.01 |
| Discretionary |
| Nov 1, 2023 | XFOR | $49.4K | Sale | 67,695 | $0.73 | Planned |
| Oct 31, 2023 | XFOR | $0 | Award | 230,645 | $N/A | Discretionary |
| Mar 10, 2023 | XFOR | $14.1K | Sale | 16,806 | $0.84 | Discretionary |
| Feb 13, 2023 | XFOR | $863 | Sale | 928 | $0.93 | Discretionary |
| Mar 1, 2022 | XFOR | $0 | Award | 97,000 | $N/A | Discretionary |
| Feb 11, 2022 | XFOR | $0 | Payment | 928 | $N/A | Discretionary |
| Mar 24, 2021 | XFOR | $0 | Award | 8,035 | $N/A | Discretionary |